Ingredion to Release 2026 Second Quarter Financial Results On August 4, 2026
Get Alerts INGR Hot Sheet
Join SI Premium – FREE
WESTCHESTER, Ill., July 14, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its second quarter 2026 financial results for the period ended June 30, 2026, before the market opens Tuesday, August 4, 2026.
Jim Zallie, chairman, president and chief executive officer and Jason Payant, vice president and interim chief financial officer, will host a conference call August 4 at 8 a.m. CT to discuss the Company's financial performance. The conference call and accompanying slide presentation will be webcast live at https://ir.ingredionincorporated.com/events-and-presentations. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the presentation. A replay of the presentation will be available on the Company's website.
ABOUT INGREDION
Ingredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2025 annual net sales of approximately $7.2 billion, the Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion’s Idea Labs® innovation centers around the world and more than 11,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature and technology together to make life better. Visit ingredion.com for more information and the latest Company news.
| CONTACTS |
| Investors: Noah Weiss, 773-896-5242 |
| Media: Rick Wion, 708-209-6323 |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ingredion’s 595 pence All-Cash Offer to Acquire Tate & Lyle Accepted by Their Shareholders
- Leonardo DRS beats estimates, raises 2026 EPS guidance
- Bristol-Myers Squibb raises annual outlook as Q2 tops estimates; shares up
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share